This site is intended for healthcare professionals only
LoginRegister
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, GemcitabineNPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, Gemcitabine
No Promotional Campaigns for GLP-1 Obesity Drugs: CDSCO Cautions Pharma FirmsDrug, Vaccine Lab Tests May Cost Up to Rs 45,000 with 5% Annual Hike
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity MarketsNatco Pharma Gets USFDA Tentative Approval for Cancer Drug Erdafitinib
SPARC Bags USFDA Rare Pediatric Disease Priority Review Voucher for SezabySPARC Bags USFDA Rare Pediatric Disease Priority Review Voucher for Sezaby
Medicine Management Streamlined as Rajasthan Notifies Pharmacist Job ChartMedicine Management Streamlined as Rajasthan Notifies Pharmacist Job Chart
CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule ApprovalCDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule...
Budget 2026: Ibrutinib, Venetoclax, Ribociclib Now Duty-Free, Cancer Drugs Cheaper for PatientsBudget 2026: Ibrutinib, Venetoclax, Ribociclib Now Duty-Free, Cancer Drugs Cheaper for Patients
Lupin Launches Dasatinib in US Market in Partnership with PharmascienceLupin Launches Dasatinib in US Market in Partnership with Pharmascience
CDSCO Cancels Kult Apps Cosmetic Import Registrations Over False LabelingAIOCD Hails Union Budget 2026 as Patient-Centric Roadmap for Pharma Growth
Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli UlcerLupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer
Industry Leaders Welcome Union Budget 2026Catalyst for Biosimilars, Innovation: Pharma Majors Applaud Biopharma Shakti Push in Union Budget...
Cipla Announces Leadership Change, USD 100 Million Investment, Approves Inzpera MergerCipla Names Arun Kakatkar as Global Chief People Officer
X